{
    "Trade/Device Name(s)": [
        "In Touch Blood Glucose Monitoring System",
        "In Touch Blood Glucose Meter",
        "In Touch Blood Glucose Test Strips",
        "In Touch Control Solution",
        "In Touch Data Management System",
        "In Touch Lancing Device",
        "In Touch Lancets",
        "In Touch Level 1 Control Solution",
        "In Touch Level 2 Control Solution"
    ],
    "Submitter Information": "EosHealth, Inc.",
    "510(k) Number": "K133584",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112653",
        "K101371"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "August 26, 2014",
    "Summary Letter Received Date": "August 27, 2014",
    "Submission Date": "September 4, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (Specified) Analyte Controls (Assayed And Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh whole capillary blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "In Touch Blood Glucose Meter",
        "In Touch Data Management System"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology",
        "Electrochemical enzymatic assay",
        "Glucose oxidase"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Quality control check"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution",
        "Software",
        "Accessory",
        "Lancing Device",
        "Lancets"
    ],
    "Document Summary": "FDA 510(k) summary for In Touch Blood Glucose Monitoring System, an OTC device for quantitative glucose measurement in capillary blood using electrochemical biosensor technology.",
    "Indications for Use Summary": "For over-the-counter quantitative measurement of glucose in fresh whole capillary blood from the fingertip by persons with diabetes in home settings; not for diagnosis or screening of diabetes or neonatal use; single-user only, not to be shared.",
    "fda_folder": "Clinical Chemistry"
}